Gusflower
Distinguished member
- Joined
- Dec 23, 2010
- Messages
- 153
- Reason
- Learn about ALS
- Country
- SWE
- State
- Skåne
- City
- Helsingborg
http://www.neuronova.com/images/pdf/fact_snn0029_091126.pdf
I received this e-mail response on the 25th of March. I just sent a new mail to see if there is any other news since results will be evaluated this summer.
I received this e-mail response on the 25th of March. I just sent a new mail to see if there is any other news since results will be evaluated this summer.
The update I can give is that the clinical study of patients in which we examine the safety and tolerability is still ongoing in Belgium. The results will be evaluated during the summer of this year if all goes according to plan we follow. We hope to continue with further studies, but it really depends on several things such as regulatory approvals, ethical approval and continued funding. We are of course working hard on all fronts, but unfortunately I can not be more specific regarding time frames for when we publish these or timeliness of any future studies.
Best regards,
Anders Haegerstrand